Header image

Journals 2025
Platelets, chromogranin A and C-reactive protein predict therapy failure of metastatic hormone-sensitive prostate cancer while miR-375 outperforms PSA in stratifying castration-resistant prostate cancer.
The Journal of Molecular Diagnostics : JMD.
2025,
S1525-1578(25),
00063-7,
ISSN: 1525-1578,
PMID: 40139458,